Kottschade, Lisa A.

Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial

Basch, E., Schrag, D., Henson, S., Jansen, J., Ginos, B., Stover, A. M., Carr, P., Spears, P. A., Jonsson, M., Deal, A. M., et al. (2022) · JAMA

Cancer survivorship and careMobile Health and mHealth Applications

Cited by 413

Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms

Delivanis, D. A., Gustafson, M. P., Bornschlegl, S., Merten, M. M., Kottschade, L., Withers, S., Dietz, A. B., & Ryder, M. (2017) · The Journal of Clinical Endocrinology & Metabolism

Cancer Immunotherapy and BiomarkersThyroid Disorders and Treatments

Cited by 278

Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: findings from the PRO-TECT trial

Basch, E., Stover, A. M., Schrag, D., Chung, A., Jansen, J., Henson, S., Carr, P., Ginos, B., Deal, A., Spears, P. A., et al. (2020) · JCO Clinical Cancer Informatics

Cancer survivorship and careMobile Health and mHealth Applications

Cited by 194

Identification and Characterization of Immune Checkpoint Inhibitor–Induced Toxicities From Electronic Health Records Using Natural Language Processing

Barman, H., Venkateswaran, S., Santo, A. D., Yoo, U., Silvert, E., Rao, K., Raghunathan, B., Kottschade, L. A., Block, M. S., Chandler, G. S., et al. (2024) · JCO Clinical Cancer Informatics

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 20